TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CERS

Cerus Corporation

Healthcare · Medical Devices

2.70$ +4.3% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Cerus Corporation (CERS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 205 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CERS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
206 198 189 185 190 201 207 213 215 222 223 205
151 144 138 135 141 152 162 169 167 174 175 157
17 12 21 12 22 20 19 16 16 20 28 18
79 66 72 71 76 80 81 78 79 83 80 56
25 36 23 24 24 30 26 31 30 30 29 31
43 40 40 36 37 38 48 55 53 56 61 66
1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3
157 144 139 135 135 144 151 157 153 157 155 134
80 68 57 54 54 64 70 84 88 101 107 86
21 20 22 21 21 22 23 31 39 46 56 33
39 24 17 17 16 22 28 31 25 28 32 34
60 60 65 65 65 65 65 57 49 41 32 35
48 53 49 50 53 56 55 55 61 64 68 70
-1,043 -1,045 -1,054 -1,060 -1,063 -1,066 -1,073 -1,079 -1,079 -1,081 -1,083 -1,086
181 181 182 185 185 185 187 191 192 192 194 201

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?